(XMCH) Xtrackers MSCI China 1C - Ratings and Ratios
Chinese Equities, Cash
Description: XMCH Xtrackers MSCI China 1C
The Xtrackers MSCI China UCITS ETF 1C CHF is a China Equity ETF listed in Switzerland, providing investors with exposure to the Chinese market. As an ETF tracking the Morningstar China TME NR USD Index, it offers a diversified portfolio of Chinese equities.
From a technical analysis perspective, the ETF is currently trading at 14.55 CHF, slightly below its 20-day Simple Moving Average (SMA) of 14.66, indicating a potential short-term bearish trend. However, its 50-day SMA at 14.32 and 200-day SMA at 14.05 are both below the current price, suggesting a longer-term bullish trend. The Average True Range (ATR) is 0.20, representing a 1.40% daily price volatility, which is relatively moderate. Considering the 52-week high and low range of 16.90 to 10.94, the ETF is currently trading near the lower end of its recent range, potentially indicating a buying opportunity.
With Assets Under Management (AUM) of 1208.02M CHF, the fund demonstrates a significant presence in the market, providing liquidity and stability. As a UCITS-compliant ETF, it adheres to strict regulatory standards, making it an attractive option for institutional and retail investors alike.
Based on the technical and fundamental data, a forecast for the Xtrackers MSCI China UCITS ETF 1C CHF can be derived. Given the current price is near the lower end of its 52-week range and the longer-term SMAs are trending upwards, a potential buying opportunity exists. If the ETF can break above its 20-day SMA and sustain a bullish trend, it may target the 52-week high of 16.90. Conversely, a failure to break above the 20-day SMA may lead to a retest of the 52-week low. Therefore, a cautious bullish outlook is warranted, with a potential upside target of 16.00-16.90 in the medium-term, contingent on a sustained break above the 20-day SMA and positive market conditions.
Additional Sources for XMCH ETF
XMCH ETF Overview
Market Cap in USD | 1,521m |
Category | China Equity |
TER | 0.65% |
IPO / Inception | 2010-06-24 |
XMCH ETF Ratings
Growth Rating | -22.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 4.64 |
Analysts | - |
Fair Price Momentum | 13.02 CHF |
Fair Price DCF | - |
XMCH Dividends
Currently no dividends paidXMCH Growth Ratios
Growth Correlation 3m | 51.8% |
Growth Correlation 12m | 70.5% |
Growth Correlation 5y | -72.9% |
CAGR 5y | -6.86% |
CAGR/Max DD 5y | -0.11 |
Sharpe Ratio 12m | 0.23 |
Alpha | 8.05 |
Beta | 0.697 |
Volatility | 22.63% |
Current Volume | 1.7k |
Average Volume 20d | 1k |
Stop Loss | 14 (-3.4%) |
As of July 09, 2025, the stock is trading at CHF 14.50 with a total of 1,700 shares traded.
Over the past week, the price has changed by +0.67%, over one month by -2.32%, over three months by +9.73% and over the past year by +19.85%.
Neither. Based on ValueRay´s Analyses, Xtrackers MSCI China 1C is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -22.78 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XMCH is around 13.02 CHF . This means that XMCH is currently overvalued and has a potential downside of -10.21%.
Xtrackers MSCI China 1C has no consensus analysts rating.
According to our own proprietary Forecast Model, XMCH Xtrackers MSCI China 1C will be worth about 14.9 in July 2026. The stock is currently trading at 14.50. This means that the stock has a potential upside of +2.76%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 14.9 | 2.8% |